Innovative Strategies and Social Media Scrutiny

6min Snip

00:00

Play full episode

Summary

Transcript

Episode notes

This chapter explores Eli Lilly's new pricing and delivery innovations in medication, which aim to improve accessibility and challenge competitors. It also delves into the implications of Meta's content moderation policies and the broader political discourse surrounding social media accountability.

Episode 397: Neal and Toby discuss Eli Lilly’s newest form of Zepbound, their blockbuster weight-loss drug that is half the price of its predecessor. Will this eliminate the competition? Then, Mark Zuckerberg writes a letter expressing his regret for demoting Covid-19 content during the pandemic as it felt ‘pressured’ from the Biden administration. Next, the Kelce brothers just scored a massive $100M deal with Amazon to take their podcast to… new heights. Meanwhile, birth rates around the world are falling and some countries are trying to pay people to start families, and it’s not working. Also, dinner sausages are becoming more and more popular as price-conscious shoppers shift to cheaper meats. Lastly, brutal heat waves sweeping across the country are forcing outdoor workers to wear high-tech cooling systems to survive.

Visit https://www.massmutual.com/ for all your financial planning needs

Get your Morning Brew Daily T-Shirt HERE: https://shop.morningbrew.com/products/morning-brew-radio-t-shirt?_pos=1&_sid=6b0bc409d&_ss=r&variant=45353879044316

Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD

Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow

Listen to Money with Katie's podcast on "The Messy Economic Truth that the "Birth Rate Panic" Reveals" Here

00:00 - Shirts at the US Open

02:40 - Eli Lilly Cutting Prices

06:30 - Zuck Covid Content Regrets

09:45 - Kelce Mega Podcast Deal

16:00 - South Korean Birth Rate

20:00 - Sausage Impact on the Economy

23:20 - Ice Pack Work Vests